Matches in Wikidata for { <http://www.wikidata.org/entity/Q61955309> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q61955309 description "assaig clínic" @default.
- Q61955309 description "clinical trial" @default.
- Q61955309 description "clinical trial" @default.
- Q61955309 description "clinical trial" @default.
- Q61955309 description "clinical trial" @default.
- Q61955309 description "ensaio clínico" @default.
- Q61955309 description "ensayo clínico" @default.
- Q61955309 description "ensayu clínicu" @default.
- Q61955309 description "essai clinique" @default.
- Q61955309 description "klinisch onderzoek" @default.
- Q61955309 description "клінічне випробування" @default.
- Q61955309 name "A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma" @default.
- Q61955309 type Item @default.
- Q61955309 label "A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma" @default.
- Q61955309 prefLabel "A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma" @default.
- Q61955309 P1132 Q61955309-CDA496B5-90A2-4DD1-A881-55DEA38D65B0 @default.
- Q61955309 P1476 Q61955309-52636E58-E4C9-4231-B5C6-CB884EA336CE @default.
- Q61955309 P17 Q61955309-28D65BD3-6F05-4996-92FD-B9C9CE3846FB @default.
- Q61955309 P17 Q61955309-3FB79E12-8089-42EF-95D9-DF9FE25CD5D2 @default.
- Q61955309 P17 Q61955309-CDB65768-2045-4551-BE95-10F2C1CE1DB4 @default.
- Q61955309 P17 Q61955309-FF7D14A3-61DA-4AB8-8101-B74321D56238 @default.
- Q61955309 P2899 Q61955309-05585025-628B-4814-9798-287A85FDAEF7 @default.
- Q61955309 P3098 Q61955309-DE4B06E0-4A71-4851-8728-84CE872BB159 @default.
- Q61955309 P31 Q61955309-3A4D764B-4AC6-438E-8F49-692B0A4A567C @default.
- Q61955309 P4844 Q61955309-3400E26A-2AA5-4BAA-9030-032C44156AB4 @default.
- Q61955309 P4844 Q61955309-C03DDFC3-79B9-43E7-884B-0F86B8CCD621 @default.
- Q61955309 P580 Q61955309-38B41448-F76E-4215-8353-2AE703965AF8 @default.
- Q61955309 P582 Q61955309-AC57C829-E8B6-4174-8EFA-A109959DF445 @default.
- Q61955309 P6099 Q61955309-ECA4C4D7-0669-4E0B-8225-70107417A495 @default.
- Q61955309 P6153 Q61955309-E5A5884E-1940-4EF8-9693-7DAB8667E11F @default.
- Q61955309 P8363 Q61955309-E03AD17D-F90E-427C-869B-526D7AAB28DA @default.
- Q61955309 P859 Q61955309-4731C7EB-F806-49BD-86D8-CFBB189CE6F7 @default.
- Q61955309 P1132 "+38" @default.
- Q61955309 P1476 "A Phase I, Two-stage, Multi-center, Open Label, Dose-escalation Study of BKM120 in Combination With Adjuvant Temozolomide and With Concomitant Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma" @default.
- Q61955309 P17 Q16 @default.
- Q61955309 P17 Q29 @default.
- Q61955309 P17 Q30 @default.
- Q61955309 P17 Q408 @default.
- Q61955309 P2899 "+18" @default.
- Q61955309 P3098 "NCT01473901" @default.
- Q61955309 P31 Q30612 @default.
- Q61955309 P4844 Q416975 @default.
- Q61955309 P4844 Q425088 @default.
- Q61955309 P580 "2011-12-30T00:00:00Z" @default.
- Q61955309 P582 "2017-05-17T00:00:00Z" @default.
- Q61955309 P6099 Q5452194 @default.
- Q61955309 P6153 Q507154 @default.
- Q61955309 P8363 Q78089383 @default.
- Q61955309 P859 Q507154 @default.